
AXA PE provides additional €100m to Ceva
AXA Private Equity has injected a further €100m into portfolio company Ceva Santé Animale, a veterinary health company.
The fresh funding, in the form of a bond financing line underwritten by AXA PE, will support the company's plans for international expansion.
The GP first invested in the company in 2007, making a capital commitment of €30m. The company's management became majority shareholders in the firm in 2007 as part of an LBO including NiXEN and Euromezzanine. IK Investment Partners, the vendor, enjoyed a 40% IRR on the sale of the company. In 2010, Sagard became a shareholder in the firm.
Company
Founded in 1999 and based in Libourne, Ceva is a veterinary health company. The firm focuses on the research, development, production and marketing of vaccines and pharmaceuticals for household animals, livestock, swine and poultry.
Ceva employs more than 3,000 staff in 43 countries and has a sales forecast of around €600m for 2012.
People
Cécile Mayer-Levi is co-head of AXA PE Private Debt and worked on the transaction alongside Guillaume Chinardet and Grégory Pernot.
Advisers
Equity (AXA PE) – Willkie Farr & Gallagher, Paul Lombard, Igor Kukhta, Virginie Syag (Legal).
Management – Weil Gotshal & Manges, David Aknin, David Malamed (Legal).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater